4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
bioAffinity Technologies, Inc. (BIAF) operates in the Diagnostics & Research industry and is headquartered in San Antonio, United States with about 57 employees. Its market capitalization is roughly $4 million. In the fiscal year ended 2025-12-31, BIAF reported $6M in revenue and ($15M) in net income.
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States.
Interactive charts & full statements → Open the BIAF valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $6M | $9M | $2M | $0M | — |
| Gross Profit | $2M | $3M | $1M | $0M | — |
| Operating Income (EBIT) | ($11M) | ($9M) | ($8M) | ($4M) | — |
| Net Income | ($15M) | ($9M) | ($8M) | ($8M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $1M | $2M | $1M | $1M | $2M |
| Gross Profit | $0M | $1M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($4M) | ($3M) | ($2M) | ($2M) | ($3M) |
| Net Income | ($4M) | ($3M) | ($5M) | ($4M) | ($3M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $11M | $6M | $8M | $12M | — |
| Total Liabilities | $4M | $4M | $3M | $1M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BIAF viewer.
About TickerBase · Data methodology & sources